IP Library Granted Patent US 12,484,957
Granted Patent B2
US 12,484,957 · App. 19/172,339 · Granted Dec 2, 2025

Devices for therapeutic nasal neuromodulation and associated methods and systems

Inventors: David Townley (County Clare, IE); Brian Shields (County Galway, IE); Ivan Keogh (Galway, IE); Michele Qi Zhan (Antioch, CA); Conor Farrell (County Mayo, IE)
Assignee: National University of Ireland, Galway
A61B18/1485A61B18/1206A61B34/25A61B2017/00199A61B2017/00292A61B2017/00862A61B2017/00867A61B2018/00273A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00648A61B2018/00672A61B2018/00815A61B2018/00821A61B2018/00875A61B18/02A61B2018/1253A61B2018/126A61B2018/1467A61B2018/1807A61B2018/1823A61B18/20A61B2090/3735A61B2090/376A61B2090/3762A61B2090/378
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,484,957
App. No.
19/172,339
Granted
Dec 2, 2025
Kind
B2
Abstract

Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.

Claims (65)

1 . A method for treating a condition within a nasal cavity of a subject, the method comprising:

providing a treatment device comprising a treatment element arranged at a distal portion of a shaft of the treatment device, the treatment element comprising a plurality of electrodes arranged in a substantially symmetrical distribution and comprising at least a first pair of bipolar electrodes and a second pair of bipolar electrodes and at least one temperature sensor,

operably coupling the treatment device to a console unit via a cable connection;

advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element contact mucosa overlying an area of posterior nasal nerve (PNN) tissue within a posterior region of the nasal cavity defined by an inferior turbinate and a middle meatus; and

controlling, via the console unit, delivery of one or more treatment applications applied via the treatment element, wherein the treatment application comprises delivery of radiofrequency (RF) energy from the two or more of the plurality of electrodes for altering transmission of signals through the PNN tissue, wherein delivery of the RF energy is conducted a plurality of times at a plurality of discrete sites along the PNN tissue in the posterior region,

wherein the treatment element delivers RF energy pursuant to a plurality of treatment parameters, wherein the treatment parameters comprise at least a predetermined time threshold and a predetermined temperature threshold,

wherein, during delivery of a treatment application of RF energy, the console unit:

continuously monitors temperature of tissue proximate the PNN tissue based on one or more temperature readings received from the at least one temperature sensor;

for each of the first and second pairs of bipolar electrodes, monitors temperature of adjacent tissue during delivery of RF energy therefrom;

continuously monitors a treatment delivery time;

stores a predetermined maximum parameter for operation of the treatment device, wherein the maximum parameter includes at least the predetermined time threshold and the predetermined temperature threshold;

automatically controls the treatment application of RF energy emitted from the two or more electrodes, based on the one or more temperature readings and elapsed time, to thereby maintain delivery of RF energy of the given treatment application for a predetermined treatment delivery time period and maintain a level of RF energy at a level sufficient to cause therapeutic neuromodulation of PNN tissue while preventing temperature of tissue from exceeding the predetermined threshold temperature, wherein the predetermined treatment delivery time period is about 10 seconds to about 12 seconds and the predetermined threshold temperature is less than 90° C.;

automatically terminates the treatment application of RF energy when the elapsed time reaches the predetermined time threshold; and

automatically terminates the treatment application of RF energy when the temperature reaches the predetermined temperature threshold.

2 . The method of claim 1 , further comprising providing, via a display, feedback information to an operator during delivery of the one or more treatment applications, wherein said feedback information comprises at least the treatment delivery time and actual temperature of tissue during delivery of RF energy thereto.

3 . The method of claim 2 , wherein the display is a touchscreen monitor for inputting treatment parameters to the console unit.

4 . The method of claim 1 , wherein the console unit comprises an energy generator configured to generate RF energy to be delivered by the two or more of the plurality of electrodes.

5 . The method of claim 4 , wherein the console unit incorporates a user interface to control, monitor, and regulate RF energy delivery to tissue by the treatment device and the treatment element.

6 . The method of claim 1 , wherein the treatment device includes a handle arranged on a proximal portion of the shaft, and the treatment element is disposed at a distal tip of the shaft and the plurality of electrodes includes electrodes which are disposed in a side by side arrangement.

7 . The method of claim 1 , wherein the shaft of the treatment device comprises a sufficiently rigid material such that the shaft can be inserted into the nasal cavity and the device is configured such that the electrodes can reach the PNN tissue in the posterior region.

8 . The method of claim 1 , wherein the plurality of electrodes comprises at least eight electrodes arranged in a grid pattern and in proximity to the thermocouple.

9 . The method of claim 1 , wherein the condition is selected from the group consisting of allergic rhinitis, non-allergic rhinitis, chronic rhinitis, acute rhinitis, chronic sinusitis, acute sinusitis, chronic rhinosinusitis, acute rhinosinusitis, and medical resistant rhinitis.

10 . The method of claim 9 , wherein RF energy treatment of the condition generates heat within submucosal tissue around a region of PNN tissue to improve symptoms of chronic rhinitis.

11 . A method for treating a condition within a nasal cavity of a subject, the method comprising:

providing a treatment device comprising a treatment element arranged at a distal portion of a shaft of the treatment device, the treatment element comprising a plurality of electrodes arranged in a substantially symmetrical distribution and comprising at least a first pair of bipolar electrodes and a second pair of bipolar electrodes and at least one temperature sensor;

operably coupling the treatment device to a console unit via a cable connection;

advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element contact mucosa overlying an area of posterior nasal nerve (PNN) tissue within a posterior region of the nasal cavity defined by an inferior turbinate and a middle meatus; and

controlling, via the console unit, delivery of one or more treatment applications applied via the treatment element, wherein the treatment application comprises delivery of radiofrequency (RF) energy from the two or more of the plurality of electrodes for altering transmission of signals through the PNN tissue, wherein delivery of the RF energy is conducted a plurality of times at a plurality of discrete sites along the PNN tissue in the posterior region,

wherein the treatment element delivers RF energy pursuant to one or more of a plurality of treatment parameters, wherein the treatment parameters comprise at least a predetermined time threshold and a predetermined temperature threshold,

wherein, during delivery of a treatment application of RF energy, the console unit:

for each of the first and second pairs of bipolar electrodes, monitors temperature of adjacent tissue during delivery of RF energy therefrom;

continuously monitors a treatment delivery time;

stores a predetermined maximum parameter for operation of the treatment device, wherein the maximum parameter includes at least the predetermined time threshold;

automatically controls the treatment application of RF energy emitted from the two or more electrodes, based, at least in part, on the elapsed time, to thereby maintain delivery of RF energy of the given treatment application for a predetermined treatment delivery time period and maintain a level of RF energy at a level sufficient to cause therapeutic neuromodulation of PNN tissue, wherein the predetermined treatment delivery time period is about 10 seconds to about 12 seconds; and

automatically terminates the treatment application of RF energy when the elapsed time reaches the predetermined time threshold.

12 . The method of claim 11 , further comprising providing, via a display, feedback information to an operator during delivery of the one or more treatment applications, wherein said feedback information comprises at least the treatment delivery time and actual temperature of tissue during delivery of RF energy thereto.

13 . The method of claim 12 , wherein the display is a touchscreen monitor for inputting treatment parameters to the console unit.

14 . The method of claim 11 , wherein the console unit comprises an energy generator configured to generate RF energy to be delivered by the two or more of the plurality of electrodes.

15 . The method of claim 14 , wherein the console unit incorporates a user interface to control, monitor, and regulate RF energy delivery to tissue by the treatment device and the treatment element.

16 . The method of claim 11 , wherein the treatment device includes a handle arranged on a proximal portion of the shaft, and the treatment element is disposed at a distal tip of the shaft and the plurality of electrodes includes electrodes which are disposed in a side by side arrangement.

17 . The method of claim 11 , wherein the shaft of the treatment device comprises a sufficiently rigid material such that the shaft can be inserted into the nasal cavity and the device is configured such that the electrodes can reach the PNN tissue in the posterior region.

18 . The method of claim 11 , wherein the plurality of electrodes comprises at least eight electrodes arranged in a grid pattern and in proximity to the thermocouple.

19 . The method of claim 1 , wherein the condition is selected from the group consisting of allergic rhinitis, non-allergic rhinitis, chronic rhinitis, acute rhinitis, chronic sinusitis, acute sinusitis, chronic rhinosinusitis, acute rhinosinusitis, and medical resistant rhinitis.

20 . The method of claim 19 , wherein RF energy treatment of the condition generates heat within submucosal tissue around a region of PNN tissue to improve symptoms of chronic rhinitis.

21 . A method for treating a condition within a nasal cavity of a subject, the method comprising:

providing a treatment device comprising a treatment element arranged at a distal portion of a shaft of the treatment device, the treatment element comprising a plurality of electrodes arranged in a substantially symmetrical distribution and comprising at least a first pair of bipolar electrodes and a second pair of bipolar electrodes and at least one temperature sensor;

operably coupling the treatment device to a console unit via a cable connection;

advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element contact mucosa overlying an area of posterior nasal nerve (PNN) tissue within a posterior region of the nasal cavity defined by an inferior turbinate and a middle meatus; and

controlling, via the console unit, delivery of one or more treatment applications applied via the treatment element, wherein the treatment application comprises delivery of radiofrequency (RF) energy from the two or more of the plurality of electrodes for altering transmission of signals through the PNN tissue, wherein delivery of the RF energy is conducted a plurality of times at a plurality of discrete sites along the PNN tissue in the posterior region,

wherein the treatment element delivers RF energy pursuant to one or more of a plurality of treatment parameters, wherein the treatment parameters comprise at least a predetermined time threshold and a predetermined temperature threshold,

wherein, during delivery of a treatment application of RF energy, the console unit:

continuously monitors temperature of tissue proximate the PNN tissue based on one or more temperature readings received from the at least one temperature sensor;

for each of the first and second pairs of bipolar electrodes, monitors temperature of adjacent tissue during delivery of RF energy therefrom;

stores a predetermined maximum parameter for operation of the treatment device, wherein the maximum parameter includes at least the predetermined temperature threshold;

automatically controls the treatment application of RF energy emitted from the two or more electrodes, based, at least in part, on the one or more temperature readings, to thereby maintain a level of RF energy at a level sufficient to cause therapeutic neuromodulation of PNN tissue while preventing temperature of tissue from exceeding the predetermined threshold temperature, wherein the predetermined threshold temperature is less than 90° C.; and

automatically terminates the treatment application of RF energy when the temperature reaches the predetermined temperature threshold.

22 . The method of claim 21 , further comprising providing, via a display, feedback information to an operator during delivery of the one or more treatment applications, wherein said feedback information comprises at least the treatment delivery time and actual temperature of tissue during delivery of RF energy thereto.

23 . The method of claim 22 , wherein the display is a touchscreen monitor for inputting treatment parameters to the console unit.

24 . The method of claim 21 , wherein the console unit comprises an energy generator configured to generate RF energy to be delivered by the two or more of the plurality of electrodes.

25 . The method of claim 24 , wherein the console unit incorporates a user interface to control, monitor, and regulate RF energy delivery to tissue by the treatment device and the treatment element.

26 . The method of claim 21 , wherein the treatment device includes a handle arranged on a proximal portion of the shaft, and the treatment element is disposed at a distal tip of the shaft and the plurality of electrodes includes electrodes which are disposed in a side by side arrangement.

27 . The method of claim 21 , wherein the shaft of the treatment device comprises a sufficiently rigid material such that the shaft can be inserted into the nasal cavity and the device is configured such that the electrodes can reach the PNN tissue in the posterior region.

28 . The method of claim 21 , wherein the plurality of electrodes comprises at least eight electrodes arranged in a grid pattern and in proximity to the thermocouple.

29 . The method of claim 21 , wherein the condition is selected from the group consisting of allergic rhinitis, non-allergic rhinitis, chronic rhinitis, acute rhinitis, chronic sinusitis, acute sinusitis, chronic rhinosinusitis, acute rhinosinusitis, and medical resistant rhinitis.

30 . The method of claim 29 , wherein RF energy treatment of the condition generates heat within submucosal tissue around a region of PNN tissue to improve symptoms of chronic rhinitis.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2025
From: KEOGH, IVAN
To: NATIONAL UNIVERSITY OF IRELAND, GALWAY
Reel/Frame 072211/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2025
From: TOWNLEY, DAVID; SHIELDS, BRIAN; QI ZHAN, MICHELE; FARRELL, CONOR
To: NATIONAL UNIVERSITY OF IRELAND, GALWAY
Reel/Frame 072211/0799 →
CHANGE OF NAME Recorded Sep 10, 2025
From: NATIONAL UNIVERSITY OF IRELAND, GALWAY
To: UNIVERSITY OF GALWAY
Reel/Frame 072211/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2025
From: UNIVERSITY OF GALWAY
To: NEURENT MEDICAL LIMITED
Reel/Frame 072212/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2025
From: TOWNLEY, DAVID; SHIELDS, BRIAN; QI ZHAN, MICHELE; FARRELL, CONOR
To: NATIONAL UNIVERSITY OF IRELAND, GALWAY
Reel/Frame 070815/0687 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2025
From: KEOGH, IVAN
To: NATIONAL UNIVERSITY OF IRELAND, GALWAY
Reel/Frame 070815/0751 →
Continuity (5)
Continuation 18678536 · May 30, 2024
Continuation 16703263 · Dec 4, 2019
Continuation 15153217 · May 12, 2016
Provisional Application 62160289 · May 12, 2015
Related Publication 20250281230A1 · Sep 11, 2025
References Cited (349)
US 874178A · De Forest · 1907 [cited by applicant]
US 3117571A · Fry et al. · 1964 [cited by applicant]
US 3538919A · Meyer · 1970 [cited by applicant]
US 3941121A · Olinger et al. · 1976 [cited by applicant]
US 3987795A · Morrison · 1976 [cited by applicant]
US 4271848A · Turner et al. · 1981 [cited by applicant]
US 4411266A · Cosman · 1983 [cited by applicant]
US 4898169A · Norman et al. · 1990 [cited by applicant]
US 5184625A · Cottone, Jr. et al. · 1993 [cited by applicant]
US 5395383A · Adams et al. · 1995 [cited by applicant]
US 5456662A · Edwards et al. · 1995 [cited by applicant]
US 5562720A · Stern et al. · 1996 [cited by applicant]
US 5575788A · Baker et al. · 1996 [cited by applicant]
US 5588429A · Isaacson et al. · 1996 [cited by applicant]
US 5697536A · Eggers et al. · 1997 [cited by applicant]
US 5697882A · Eggers et al. · 1997 [cited by applicant]
US 5746224A · Edwards · 1998 [cited by applicant]
US 5766605A · Sanders et al. · 1998 [cited by applicant]
US 5800429A · Edwards · 1998 [cited by applicant]
US 5823197A · Edwards · 1998 [cited by applicant]
US 5827277A · Edwards · 1998 [cited by applicant]
US 5836947A · Fleischman et al. · 1998 [cited by applicant]
US 5843026A · Edwards et al. · 1998 [cited by applicant]
US 6033397A · Laufer et al. · 2000 [cited by applicant]
US 6045532A · Eggers et al. · 2000 [cited by applicant]
US 6053172A · Hovda et al. · 2000 [cited by applicant]
US 6063079A · Hovda et al. · 2000 [cited by applicant]
US 6106518A · Wittenberger et al. · 2000 [cited by applicant]
US 6139527A · Laufer et al. · 2000 [cited by applicant]
US 6142991A · Schatzberger · 2000 [cited by applicant]
US 6273886B1 · Edwards et al. · 2001 [cited by applicant]
US 6332880B1 · Yang et al. · 2001 [cited by applicant]
US 6352533B1 · Ellman et al. · 2002 [cited by applicant]
US 6517534B1 · McGovern et al. · 2003 [cited by applicant]
US 6517535B2 · Edwards · 2003 [cited by applicant]
US 6520185B1 · Bommannan et al. · 2003 [cited by applicant]
US 6529756B1 · Phan et al. · 2003 [cited by applicant]
US 6594518B1 · Benaron et al. · 2003 [cited by applicant]
US 6595988B2 · Wittenberger et al. · 2003 [cited by applicant]
US 6626899B2 · Houser et al. · 2003 [cited by applicant]
US 6652548B2 · Evans et al. · 2003 [cited by applicant]
US 6669689B2 · Lehmann et al. · 2003 [cited by applicant]
US 6685648B2 · Flaherty et al. · 2004 [cited by applicant]
US 6746474B2 · Saadat · 2004 [cited by applicant]
US 7195629B2 · Behl et al. · 2007 [cited by applicant]
US 7232458B2 · Saadat · 2007 [cited by applicant]
US 7285119B2 · Stewart et al. · 2007 [cited by applicant]
US 7500985B2 · Saadat · 2009 [cited by applicant]
US 7524318B2 · Young et al. · 2009 [cited by applicant]
US 7608275B2 · Deem et al. · 2009 [cited by applicant]
US 7654997B2 · Makower et al. · 2010 [cited by applicant]
US 7655243B2 · Deem et al. · 2010 [cited by applicant]
US 7758571B2 · Saadat · 2010 [cited by applicant]
US 7771409B2 · Chang et al. · 2010 [cited by applicant]
US 7803150B2 · Chang et al. · 2010 [cited by applicant]
US 8105817B2 · Deem et al. · 2012 [cited by applicant]
US 8133497B2 · Deem et al. · 2012 [cited by applicant]
US 8231613B2 · Baxter et al. · 2012 [cited by applicant]
US 8338164B2 · Deem et al. · 2012 [cited by applicant]
US 8372068B2 · Truckai · 2013 [cited by applicant]
US 8382746B2 · Williams et al. · 2013 [cited by applicant]
US 8460181B2 · Saadat et al. · 2013 [cited by applicant]
US 8463359B2 · Saadat et al. · 2013 [cited by applicant]
US 8512324B2 · Abboud et al. · 2013 [cited by applicant]
US 8636684B2 · Deem et al. · 2014 [cited by applicant]
US 8747401B2 · Gonzalez et al. · 2014 [cited by applicant]
US 8920414B2 · Stone et al. · 2014 [cited by applicant]
US 8936594B2 · Wolf et al. · 2015 [cited by applicant]
US 8939970B2 · Stone et al. · 2015 [cited by applicant]
US 8961391B2 · Deem et al. · 2015 [cited by applicant]
US 8986301B2 · Wolf et al. · 2015 [cited by applicant]
US 8996137B2 · Ackermann et al. · 2015 [cited by applicant]
US 9055965B2 · Chang et al. · 2015 [cited by applicant]
US 9072597B2 · Wolf et al. · 2015 [cited by applicant]
US 9101384B2 · Makower et al. · 2015 [cited by applicant]
US 9179964B2 · Wolf et al. · 2015 [cited by applicant]
US 9179967B2 · Wolf et al. · 2015 [cited by applicant]
US 9179973B2 · Nabutovsky et al. · 2015 [cited by applicant]
US 9233245B2 · Lamensdorf et al. · 2016 [cited by applicant]
US 9237924B2 · Wolf et al. · 2016 [cited by applicant]
US 9333023B2 · Wittenberger · 2016 [cited by applicant]
US 9370649B2 · Chang et al. · 2016 [cited by applicant]
US 9415194B2 · Wolf et al. · 2016 [cited by applicant]
US 9433463B2 · Wolf et al. · 2016 [cited by applicant]
US 9440065B2 · Ackermann et al. · 2016 [cited by applicant]
US 9452010B2 · Wolf et al. · 2016 [cited by applicant]
US 9486278B2 · Wolf et al. · 2016 [cited by applicant]
US 9498278B2 · Couture et al. · 2016 [cited by applicant]
US 9498283B2 · Deem et al. · 2016 [cited by applicant]
US 9526571B2 · Wolf et al. · 2016 [cited by applicant]
US 9649156B2 · Jenson et al. · 2017 [cited by applicant]
US 9655667B2 · Hon · 2017 [cited by applicant]
US 9687288B2 · Saadat · 2017 [cited by applicant]
US 9687296B2 · Wolf et al. · 2017 [cited by applicant]
US 9700707B2 · Deem et al. · 2017 [cited by applicant]
US 9737702B2 · Ackermann et al. · 2017 [cited by applicant]
US 9763723B2 · Saadat · 2017 [cited by applicant]
US 9763743B2 · Lin et al. · 2017 [cited by applicant]
US 9788886B2 · Wolf et al. · 2017 [cited by applicant]
US 9801752B2 · Wolf et al. · 2017 [cited by applicant]
US 9888957B2 · Wolf et al. · 2018 [cited by applicant]
US 9913682B2 · Wolf et al. · 2018 [cited by applicant]
US 9943361B2 · Wolf et al. · 2018 [cited by applicant]
US 10022529B2 · Deem et al. · 2018 [cited by applicant]
US 10028780B2 · Wolf et al. · 2018 [cited by applicant]
US 10028781B2 · Saadat · 2018 [cited by applicant]
US 10052465B2 · Deem et al. · 2018 [cited by applicant]
US 10155108B2 · Ackermann et al. · 2018 [cited by applicant]
US 10159538B2 · Lin et al. · 2018 [cited by applicant]
US 10201687B2 · Saadat · 2019 [cited by applicant]
US 10238861B2 · Ackermann et al. · 2019 [cited by applicant]
US 10252048B2 · Loudin et al. · 2019 [cited by applicant]
US 10265115B2 · Wolf et al. · 2019 [cited by applicant]
US 10307200B2 · Saadat · 2019 [cited by applicant]
US 10335221B2 · Wolf et al. · 2019 [cited by applicant]
US 10363094B2 · Brannan et al. · 2019 [cited by applicant]
US 10376300B2 · Wolf et al. · 2019 [cited by applicant]
US 10398489B2 · Wolf et al. · 2019 [cited by applicant]
US 10448985B2 · Saadat · 2019 [cited by applicant]
US 10456185B2 · Wolf et al. · 2019 [cited by applicant]
US 10456186B1 · Wolf et al. · 2019 [cited by applicant]
US 10485603B2 · Wolf et al. · 2019 [cited by applicant]
US 10588682B2 · Kelly et al. · 2020 [cited by applicant]
US 10610675B2 · Deem et al. · 2020 [cited by applicant]
US 10687883B2 · Aklog et al. · 2020 [cited by applicant]
US 10695557B1 · Townley et al. · 2020 [cited by applicant]
US 10729897B2 · Deem et al. · 2020 [cited by applicant]
US 10894011B2 · Deem et al. · 2021 [cited by applicant]
US 11033318B2 · Wolf et al. · 2021 [cited by applicant]
US 11241271B2 · Wolf et al. · 2022 [cited by applicant]
US 11304746B2 · Wolf et al. · 2022 [cited by applicant]
US 11679077B2 · Deem et al. · 2023 [cited by applicant]
US 11766286B2 · Wolf et al. · 2023 [cited by applicant]
US 20020068930A1 · Tasto et al. · 2002 [cited by applicant]
US 20020072742A1 · Schaefer et al. · 2002 [cited by applicant]
US 20020177765A1 · Bowe et al. · 2002 [cited by applicant]
US 20030016085A1 · Yamazaki · 2003 [cited by applicant]
US 20030212394A1 · Pearson et al. · 2003 [cited by applicant]
US 20050080409A1 · Young et al. · 2005 [cited by applicant]
US 20050171536A1 · Phan et al. · 2005 [cited by applicant]
US 20050171574A1 · Rubinsky et al. · 2005 [cited by applicant]
US 20050171582A1 · Matlock · 2005 [cited by applicant]
US 20050171583A1 · Mosher et al. · 2005 [cited by applicant]
US 20050187546A1 · Bek et al. · 2005 [cited by applicant]
US 20050240147A1 · Makower et al. · 2005 [cited by applicant]
US 20050283148A1 · Janssen et al. · 2005 [cited by applicant]
US 20050288730A1 · Deem et al. · 2005 [cited by applicant]
US 20060036237A1 · Davison et al. · 2006 [cited by applicant]
US 20060055942A1 · Krattiger · 2006 [cited by applicant]
US 20060100620A1 · Daniel et al. · 2006 [cited by applicant]
US 20060106375A1 · Werneth et al. · 2006 [cited by applicant]
US 20060116599A1 · Davis · 2006 [cited by applicant]
US 20060149226A1 · McCullagh et al. · 2006 [cited by applicant]
US 20060247683A1 · Danek et al. · 2006 [cited by applicant]
US 20070006975A1 · Corghi · 2007 [cited by applicant]
US 20070031341A1 · DiMauro et al. · 2007 [cited by applicant]
US 20070032786A1 · Francischelli · 2007 [cited by applicant]
US 20070083194A1 · Kunis et al. · 2007 [cited by applicant]
US 20070083195A1 · Werneth et al. · 2007 [cited by applicant]
US 20070093803A1 · Dalbec et al. · 2007 [cited by applicant]
US 20070129760A1 · Demarais et al. · 2007 [cited by applicant]
US 20070173760A1 · Fedenia et al. · 2007 [cited by applicant]
US 20070219600A1 · Gertner et al. · 2007 [cited by applicant]
US 20070233191A1 · Parmer · 2007 [cited by applicant]
US 20070265608A1 · Hernandez · 2007 [cited by applicant]
US 20070287994A1 · Patel · 2007 [cited by applicant]
US 20070299433A1 · Williams et al. · 2007 [cited by applicant]
US 20080021369A1 · Deem et al. · 2008 [cited by applicant]
US 20080154250A1 · Makower et al. · 2008 [cited by applicant]
US 20080287908A1 · Muni et al. · 2008 [cited by applicant]
US 20090198216A1 · Muni et al. · 2009 [cited by applicant]
US 20090306644A1 · Mayse et al. · 2009 [cited by applicant]
US 20090318914A1 · Utley et al. · 2009 [cited by applicant]
US 20100049187A1 · Carlton et al. · 2010 [cited by applicant]
US 20100057048A1 · Eldredge · 2010 [cited by applicant]
US 20100168737A1 · Grunewald · 2010 [cited by applicant]
US 20100204560A1 · Salahieh et al. · 2010 [cited by applicant]
US 20100305715A1 · Mathis et al. · 2010 [cited by applicant]
US 20110004207A1 · Wallace et al. · 2011 [cited by applicant]
US 20110152855A1 · Mayse et al. · 2011 [cited by applicant]
US 20110238057A1 · Moss et al. · 2011 [cited by applicant]
US 20110264086A1 · Ingle · 2011 [cited by applicant]
US 20120078377A1 · Gonzales et al. · 2012 [cited by applicant]
US 20120191003A1 · Garabedian · 2012 [cited by applicant]
US 20120259326A1 · Brannan et al. · 2012 [cited by applicant]
US 20120323214A1 · Shantha · 2012 [cited by applicant]
US 20120323227A1 · Wolf et al. · 2012 [cited by applicant]
US 20120323232A1 · Wolf et al. · 2012 [cited by applicant]
US 20130018367A1 · Wu et al. · 2013 [cited by applicant]
US 20130123778A1 · Richardson et al. · 2013 [cited by applicant]
US 20130158475A1 · Xia et al. · 2013 [cited by applicant]
US 20130165916A1 · Mathur et al. · 2013 [cited by applicant]
US 20130172877A1 · Subramaniam et al. · 2013 [cited by applicant]
US 20130178910A1 · Azamian et al. · 2013 [cited by applicant]
US 20130253387A1 · Bonutti et al. · 2013 [cited by applicant]
US 20130253389A1 · Juto et al. · 2013 [cited by applicant]
US 20130282084A1 · Mathur et al. · 2013 [cited by applicant]
US 20130289552A1 · Young · 2013 [cited by applicant]
US 20140005706A1 · Gelfand et al. · 2014 [cited by applicant]
US 20140018792A1 · Gang et al. · 2014 [cited by applicant]
US 20140025069A1 · Willard et al. · 2014 [cited by applicant]
US 20140074091A1 · Arya et al. · 2014 [cited by applicant]
US 20140100557A1 · Bohner et al. · 2014 [cited by applicant]
US 20140114233A1 · Deem et al. · 2014 [cited by applicant]
US 20140180196A1 · Stone et al. · 2014 [cited by applicant]
US 20140200581A1 · Aluru et al. · 2014 [cited by applicant]
US 20140243793A1 · Morriss et al. · 2014 [cited by applicant]
US 20140276752A1 · Wang et al. · 2014 [cited by applicant]
US 20140303665A1 · Gerrans et al. · 2014 [cited by applicant]
US 20150006606A1 · Fleury et al. · 2015 [cited by applicant]
US 20150018818A1 · Willard et al. · 2015 [cited by applicant]
US 20150031946A1 · Saadat et al. · 2015 [cited by applicant]
US 20150066006A1 · Srivastava · 2015 [cited by applicant]
US 20150112321A1 · Cadouri · 2015 [cited by applicant]
US 20150119881A1 · Bagley et al. · 2015 [cited by applicant]
US 20150150624A1 · Petersohn · 2015 [cited by applicant]
US 20150164571A1 · Saadat · 2015 [cited by applicant]
US 20150182282A1 · Zemel et al. · 2015 [cited by applicant]
US 20150202003A1 · Wolf et al. · 2015 [cited by applicant]
US 20150257754A1 · Weng et al. · 2015 [cited by applicant]
US 20150257824A1 · Mauch · 2015 [cited by applicant]
US 20150257825A1 · Kelly et al. · 2015 [cited by applicant]
US 20150265812A1 · Lalonde · 2015 [cited by applicant]
US 20150289750A1 · Stigall et al. · 2015 [cited by applicant]
US 20150297282A1 · Cadouri · 2015 [cited by applicant]
US 20150313669A1 · Darmos et al. · 2015 [cited by applicant]
US 20150351836A1 · Prutchi · 2015 [cited by applicant]
US 20160008053A1 · Mathur et al. · 2016 [cited by applicant]
US 20160015450A1 · Wolf et al. · 2016 [cited by applicant]
US 20160045277A1 · Lin et al. · 2016 [cited by applicant]
US 20160120598A1 · Brink et al. · 2016 [cited by applicant]
US 20160128767A1 · Azamian et al. · 2016 [cited by applicant]
US 20160250474A1 · Stack et al. · 2016 [cited by applicant]
US 20160287315A1 · Wolf et al. · 2016 [cited by applicant]
US 20160331459A1 · Townley et al. · 2016 [cited by applicant]
US 20160354136A1 · Saadat · 2016 [cited by applicant]
US 20170071494A1 · Solis et al. · 2017 [cited by applicant]
US 20170095252A1 · Smith et al. · 2017 [cited by applicant]
US 20170095288A1 · Wolf et al. · 2017 [cited by applicant]
US 20170151014A1 · Perfler · 2017 [cited by applicant]
US 20170209199A1 · Wolf et al. · 2017 [cited by applicant]
US 20170215950A1 · Gross et al. · 2017 [cited by applicant]
US 20170215952A1 · Nair · 2017 [cited by applicant]
US 20170231474A1 · Saadat et al. · 2017 [cited by applicant]
US 20170231651A1 · Dinger et al. · 2017 [cited by applicant]
US 20170245924A1 · Wolf et al. · 2017 [cited by applicant]
US 20170252089A1 · Hester et al. · 2017 [cited by applicant]
US 20170252100A1 · Wolf et al. · 2017 [cited by applicant]
US 20170266422A1 · Deem et al. · 2017 [cited by applicant]
US 20170312021A1 · Pilcher et al. · 2017 [cited by applicant]
US 20180042471A1 · Chandler et al. · 2018 [cited by applicant]
US 20180049802A1 · Yang et al. · 2018 [cited by applicant]
US 20180063678A1 · Zhu et al. · 2018 [cited by applicant]
US 20180078327A1 · Lin et al. · 2018 [cited by applicant]
US 20180103994A1 · Fox et al. · 2018 [cited by applicant]
US 20180125560A1 · Saadat et al. · 2018 [cited by applicant]
US 20180133460A1 · Townley et al. · 2018 [cited by applicant]
US 20180153375A1 · Saadat et al. · 2018 [cited by applicant]
US 20180161577A1 · Goedeke et al. · 2018 [cited by applicant]
US 20180168503A1 · Waldhauser et al. · 2018 [cited by applicant]
US 20180169414A1 · Goedeke et al. · 2018 [cited by applicant]
US 20180177542A1 · Wolf et al. · 2018 [cited by applicant]
US 20180177546A1 · Dinger et al. · 2018 [cited by applicant]
US 20180185085A1 · Wolf et al. · 2018 [cited by applicant]
US 20180228533A1 · Wolf et al. · 2018 [cited by applicant]
US 20180317993A1 · Saadat · 2018 [cited by applicant]
US 20180317997A1 · Dinger et al. · 2018 [cited by applicant]
US 20180344378A1 · Wolf et al. · 2018 [cited by applicant]
US 20180344411A1 · Fahey et al. · 2018 [cited by applicant]
US 20190069949A1 · Vrba et al. · 2019 [cited by applicant]
US 20190076185A1 · Dinger et al. · 2019 [cited by applicant]
US 20190083157A1 · Saadat · 2019 [cited by applicant]
US 20190175242A1 · Wolf et al. · 2019 [cited by applicant]
US 20190223944A1 · Coates · 2019 [cited by applicant]
US 20190231409A1 · Wolf et al. · 2019 [cited by applicant]
US 20190231429A1 · Townley et al. · 2019 [cited by applicant]
US 20190239953A1 · Townley et al. · 2019 [cited by applicant]
US 20190239954A1 · Townley et al. · 2019 [cited by applicant]
US 20190239955A1 · Townley et al. · 2019 [cited by applicant]
US 20190239956A1 · Townley et al. · 2019 [cited by applicant]
US 20190239957A1 · Townley et al. · 2019 [cited by applicant]
US 20190282289A1 · Wolf et al. · 2019 [cited by applicant]
US 20190314620A1 · Chang et al. · 2019 [cited by applicant]
US 20200078134A1 · Loyd et al. · 2020 [cited by applicant]
US 20200086112A1 · Townley et al. · 2020 [cited by applicant]
US 20200107882A1 · Townley et al. · 2020 [cited by applicant]
US 20200129223A1 · Angeles et al. · 2020 [cited by applicant]
US 20200289185A1 · Forsyth et al. · 2020 [cited by applicant]
US 20210315627A1 · Babkin et al. · 2021 [cited by applicant]
EP 2929852A1 · 2015 [cited by applicant]
JP 2001120565A · 2001 [cited by applicant]
JP 2001526077A · 2001 [cited by applicant]
JP 2007537784A · 2007 [cited by applicant]
JP 2009538641A · 2009 [cited by applicant]
JP 2012143573A · 2012 [cited by applicant]
JP 2015507964A · 2015 [cited by applicant]
JP 2018515314A · 2018 [cited by applicant]
WO 9410921A1 · 1994 [cited by applicant]
WO 0117450A1 · 2001 [cited by applicant]
WO 2007008954A2 · 2007 [cited by applicant]
WO 2009154456A1 · 2009 [cited by applicant]
WO 2010077980A1 · 2010 [cited by applicant]
WO 2015013252A1 · 2015 [cited by applicant]
WO 2015048806A2 · 2015 [cited by applicant]
WO 2016134264A1 · 2016 [cited by applicant]
WO 2016183337A2 · 2016 [cited by applicant]
WO 2018087601A1 · 2018 [cited by applicant]
WO 2021205230A1 · 2021 [cited by applicant]
WO 2021205231A1 · 2021 [cited by applicant]
WO 2021260435A1 · 2021 [cited by applicant]
Aerin Medical FDA 510(k) Summary—510(k) No. K150637, dated Oct. 23, 2015 (8 pages). [cited by applicant]
Aerin Medical FDA 510(k) Summary—510(k) No. K161994, dated Aug. 19, 2016 (6 pages). [cited by applicant]
Aerin Medical FDA 510(k) Summary—510(k) No. K162810, dated Dec. 9, 2016 (7 pages). [cited by applicant]
Aerin Medical FDA 510(k) Summary—510(k) No. K172529, dated Nov. 2, 2017 (7 pages). [cited by applicant]
Aerin Medical FDA 510(k) Summary—510(k) No. K192471, dated Sep. 9, 2019 (7 pages). [cited by applicant]
Aerin Medical FDA 510(k) Summary—510(k) No. K200300, dated Mar. 13, 2020 (6 pages). [cited by applicant]
Annotated Perfler Fig 11 (2022). [cited by applicant]
Anonymous: Flexible electronics—Wikipedia, Aug. 8, 202, pp. 1-9. [cited by applicant]
Arora, 1980, Cryodestruction of Vidian Nerve Branches, Indian Journal of Otolaryngology, 32(3):80-82. [cited by applicant]
Chen, 2005, Radiofrequency treatment of nasal posterior-under nerve ethmoidal nerve and infraturbinal for perennial allergic rhinitis under nasal endoscope, China Journal of Endoscopy, 11(3):239-243. [cited by applicant]
Fang, 2005, Nasal endoscopy combined with multiple radiofrequency for perennial allergic rhinitis, J. First Mil. Medic Univ., 25(7):876-877. [cited by applicant]
Horesh, 2006, Some novel approaches in modelling and image reconstruction for multi-frequency Electrical Impedance Tomography of the human brain, Thesis (Ph.D.)—University of London, University College London (United Ki… [cited by applicant]
Ikeda, 2008, Effect of resection of the posterior nasal nerve on functional and morphological changes in the inferior turbinate mucosa, Acta Oto-Laryngologica, 128, pp. 1337-1341. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2016/032132, filed May 12, 2016, Applicant: National University of Ireland, Galway, Date of Mailing: Nov. 14, 2016, 26 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2017/001541, date of mailing: Apr. 3, 2018, 15 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2019/001298, date of mailing May 12, 2020, 15 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2020/000544, date of mailing Jan. 11, 2021, 15 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2021/000234, date of mailing: Aug. 6, 2021, 14 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2021/000243, date of mailing: Aug. 25, 2021, 15 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2021/000597, date of mailing: Jan. 22, 2022, 18 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2021/000667, date of mailing: Feb. 2, 2022, 17 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2021/000699, date mailing: Feb. 4, 2022, 28 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2021/000700, date of mailing: Apr. 4, 2022, 20 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Patent Application No. PCT/IB2020/000544, date of mailing Jan. 11, 2021, 15 pages. [cited by applicant]
Kanaya, 2009, Endoscopic posterior nasal neurectomy: an alternative to Vidian neurectomy, Clinical and Experimental Allergy Reviews, pp. 24-27. [cited by applicant]
Kikawada, 2007, Endoscopic posterior nasal neurectomy: An alternative to vidian neurectomy, Operative Techniques in Otolaryngology, 18(4), 5 pages. [cited by applicant]
Kobayashi, 2012, Resection of peripheral branches of the posterior nasal nerve compared to conventional posterior neuectomy in severe allergic rhinitis, Auris Nasus Larynx, 39 (2012):593-596. [cited by applicant]
Kong, 2005, Low-temperature plasma ablation of inferior turbinate for the treatment of perennial allergic rhinitis, 19:5 J Clin Otorhinolaryngol (China), 19:5:214. [cited by applicant]
Lane, 2004, Nasal anatomy and physiology, Facial Plast Surg Clin North Am., 12(4):387-395. [cited by applicant]
Lee, 2003, Sampling and Reconstruction, In: Structure and Interpretation of Singals and Systems, Reading, MA: Addison-Wesley, ISBN: 0-201-74551-8, Pearson Education, Inc., pp. 373-392. [cited by applicant]
Liang, 1999, Radiofrequency treatment of ethmoidal nerve with allergic rhinitis under nasal endoscopy, J. Clin Otorhinolaryngol, 13(8):341-342. [cited by applicant]
Lin, 2003, Radiofrequency for the treatment of allergic rhinits refactory to medical therapy, The Laryngoscope, 113, pp. 673-678. [cited by applicant]
Lin, 2010, Long-term results of radiofrequency turbinoplasty for allergic rhinits refactor to medical therapy, Arch Otolaryngol Head Neck Surg, 136(9) 4 pages. [cited by applicant]
Min, 2015, Impedance Detection, In: Li, D. (eds) Encyclopedia of Microfluidics and Nanofluidics, Springer, New York, NY, https://doi.org/10.1007/978-1-4614-5491-5_1783, pp. 1333-1472. [cited by applicant]
Neubauer, 2022, Endothelial cells and coagulation, Cell Tissue Res, 387:391-398. [cited by applicant]
Ozenbeger, 1970, Cryosurgery in chronic rhinitis, The Laryngoscope, vol. 8, issue 5, pp. 723-734. [cited by applicant]
Ozenberger, 1973, Cryosurgery for the treatment of chronic rhinitis, The Laryngoscope, vol. 83, issue 4, pp. 508-516. [cited by applicant]
Paterno, 2009, Frequency-dpmain reconstruction of singals in electrical bioimpedance spectroscopy, Med Biol Eng Comput, 47(10):1093-1102. [cited by applicant]
Yang, 2014, Electrical Impedance Tomography: Algorithms and Application, University of Bath, 143 pages. [cited by applicant]